MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 53 filers reported holding MERSANA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $110,966,000 | -40.4% | 5,959,520 | -25.1% | 4.70% | -37.3% |
Q2 2020 | $186,253,000 | +167.0% | 7,959,520 | -33.5% | 7.49% | +105.5% |
Q1 2020 | $69,748,000 | +1.7% | 11,963,649 | 0.0% | 3.64% | +12.4% |
Q4 2019 | $68,552,000 | +262.7% | 11,963,649 | 0.0% | 3.24% | +107.2% |
Q3 2019 | $18,903,000 | -60.8% | 11,963,649 | +0.6% | 1.56% | -53.6% |
Q2 2019 | $48,172,000 | -23.0% | 11,894,267 | 0.0% | 3.38% | +3.9% |
Q1 2019 | $62,564,000 | +88.3% | 11,894,267 | +46.0% | 3.25% | +146.4% |
Q4 2018 | $33,229,000 | -59.2% | 8,144,267 | 0.0% | 1.32% | -62.5% |
Q3 2018 | $81,443,000 | -44.0% | 8,144,267 | 0.0% | 3.51% | -48.4% |
Q2 2018 | $145,457,000 | +13.3% | 8,144,267 | 0.0% | 6.81% | +19.3% |
Q1 2018 | $128,435,000 | -4.0% | 8,144,267 | 0.0% | 5.71% | +3.1% |
Q4 2017 | $133,810,000 | -5.0% | 8,144,267 | 0.0% | 5.54% | +12.4% |
Q3 2017 | $140,814,000 | +23.8% | 8,144,267 | 0.0% | 4.93% | +19.1% |
Q2 2017 | $113,775,000 | – | 8,144,267 | – | 4.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |